Resources
Select from the drop-down menu below to read the most up-to-date news about pelareorep.
October 1, 2018 | Publication
Ilett et al, Cancer Immunology Research, 2018
June 15, 2018 | Publication
Mostafa et al, Cancers, 2018
June 1, 2018 | Poster
Mahalingam et al, ASCO GI, 2018
June 1, 2018 | Poster
Grey Wilkinson et al, ASCO, 2018
May 25, 2018 | Publication
Mahalingam et al, Cancers, 2018
April 1, 2018 | Poster
Sanjay Goel et al, AACR, 2018
April 1, 2018 | Poster
Grey Wilkinson et al, AACR, 2018
April 1, 2018 | Poster
Pandha et al, IOVC, 2018
Page 10 of 14
Expanded Access
Oncolytics believes that participating in clinical trials is the best way for patients to access pelareorep. We are not currently able to fulfill expanded access requests at this time.
Information on many of Oncolytics clinical trials can be found at ClinicalTrials.gov. If a treating doctor would like additional information, the doctor should formally contact Oncolytics at info@oncolyticsbiotech.com.
Contact Us
For questions regarding our science, partnership opportunities, or other inquiries, we encourage you to reach out.